Bowel Disease Clinical Trials in Hangzhou, Zhejiang
6 recruitingHangzhou, Zhejiang, China
Showing 1–6 of 6 trials
Recruiting
Phase 1
A Phase I Study to Evaluate the Safety/Tolerability of BDHK-2009 Tablets in Healthy Adult
IBD (Inflammatory Bowel Disease)Ulcerative Colitis (UC)CD - Crohn's Disease+2 more
Benethera (Shaoxing) Biotechnology Co., Ltd.68 enrolled1 locationNCT07632573
Recruiting
A Prospective Observational Study on the Efficacy and Safety of Guselkumab in the Treatment of Crohn's Disease Patients Previously Treated With Ustekinumab
Inflamatory Bowel Disease (Crohn's and Ulcerative Colitis)Inflamatory Bowel Disease
Second Affiliated Hospital, School of Medicine, Zhejiang University60 enrolled1 locationNCT07487480
Recruiting
A Prospective Cohort Study Evaluating the Efficacy and Safety of Guselkumab (GUS) With JAK Inhibitors in Patients With Difficult-To-Treat Inflammatory Bowel Disease (IBD)
Inflamatory Bowel Disease
Second Affiliated Hospital, School of Medicine, Zhejiang University80 enrolled1 locationNCT07487311
Recruiting
Guselkumab Vs Ustekinumab in Stricturing Crohn's Disease
IBD (Inflammatory Bowel Disease)Stricture; BowelCD - Crohn's Disease
Second Affiliated Hospital, School of Medicine, Zhejiang University100 enrolled1 locationNCT07444060
Recruiting
Prophylactic Dexamethasone Before Infliximab in Moderate-to-Severe IBD
Inflammatory Bowel Disease (IBD)CD - Crohn's DiseaseUC - Ulcerative Colitis
Second Affiliated Hospital, School of Medicine, Zhejiang University300 enrolled1 locationNCT07385131
Recruiting
Phase 1
Phase 1 Study for IPG11406 in Health Volunteer
Inflammatory Bowel Diseases
Nanjing Immunophage Biotech Co., Ltd66 enrolled1 locationNCT06255834